Earnings per Share

9 Months Ended

Sep. 30, 2024

15. EARNINGS PER SHARE

We compute basic earnings per share by dividing net income attributable to Core Laboratories Inc. by the number of weighted average common shares outstanding during the period. Diluted earnings per share includes the incremental effect of contingently issuable shares from performance and restricted stock awards, as determined using the treasury stock method. The Redomestication Transaction had no effect on earnings per share for the periods presented.

The following table summarizes the calculation of weighted average common shares outstanding used in the computation of basic and diluted earnings per share (in thousands):


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Weighted average common shares outstanding - basic		46,922		46,692		46,897		46,667
Effect of dilutive securities:
Restricted shares		108		106		76		96
Performance shares		790		806		717		773
Weighted average common shares outstanding - diluted		47,820		47,604		47,690		47,536